Healthcare (SH:603313) Xin Lang Cai Jing·2025-11-07 08:32Core Viewpoint - The company has demonstrated significant recovery in profitability and steady growth in overseas markets, with a positive outlook for future revenue and profit growth. Financial Performance - For Q1-Q3 2025, the company achieved revenue of 6.756 billion, a year-on-year increase of 10.29%, and a net profit attributable to shareholders of 161 million, up 205.18% [1] - In Q3 2025 alone, the company reported revenue of 2.440 billion, an increase of 11.98%, and a net profit of 46 million, up 122.55% [1] Overseas Business Growth - In Q1-Q3 2025, North America generated revenue of 3.466 billion (up 10.49%), Europe 1.456 billion (up 1.22%), domestic revenue 1.171 billion (up 11.59%), and other regions 0.452 billion (up 33.03%) [2] - The company has completed its overseas warehouse strategy in the U.S. and is actively expanding in Europe, which is expected to become a significant growth area for its online business [2] Product and Channel Breakdown - Revenue from various products in Q1-Q3 2025: mattresses 3.606 billion (up 14.02%), pillows 468 million (up 7.89%), sofas 885 million (up 4.12%), electric beds 507 million (up 6.78%), and others 1.079 billion (up 3.44%) [3] - Revenue by channel: offline 1.954 billion (up 2.93%), online 1.982 billion (up 66.07%), and bulk sales 2.609 billion (down 9.17%) [3] Cost Reduction and Efficiency Improvement - The gross margin for Q1-Q3 2025 was 39.48%, an increase of 2.25 percentage points, while management and R&D expense ratio was 7.77% (down 0.08 percentage points) and financial expense ratio was 2.41% (down 1.87 percentage points) [4] - Sales expenses increased to 1.730 billion (up 23.70%), primarily due to rising e-commerce operational costs aimed at enhancing brand influence [4] Profit Forecast and Valuation - The company forecasts revenues of 9.436 billion, 10.799 billion, and 12.366 billion for 2025-2027, with year-on-year growth rates of 11.68%, 14.44%, and 14.51% respectively [5] - Expected net profits for the same period are 248 million (turning profitable), 358 million (up 44.18%), and 457 million (up 27.52%), indicating a gradual recovery in profit margins [5]